NCT01057017View on ClinicalTrials.gov

First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

December 31, 2011

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

intervention

Trial Locations (1)

02906

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
collaborator

Rhode Island Hospital

OTHER

collaborator

The Miriam Hospital

OTHER

lead

Brown University

OTHER